Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.

Aim This cross-sectional analysis of the New Orleans Alcohol Use in HIV (NOAH) study assesses whether current and lifetime alcohol use in people living with HIV (PLWH) are associated with greater liver disease and how hepatitis C-viral (HCV) co-infection (HIV/HCV+) modifies the association. Methods...

Descripción completa

Detalles Bibliográficos
Publicado en:Alcohol & Alcoholism Vol. 55; no. 1; pp. 28 - 37
Autores principales: Ferguson, Tekeda F, Rosen, Erika, Carr, Rotonya, Brashear, Meghan, Simon, Liz, Theall, Katherine P, Ronis, Martin J, Welsh, David A, Molina, Patricia E
Formato: research tables/charts Journal Article
Publicado: Oxford University Press / USA Jan2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=141628102&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 141628102
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        07350414
        FA3
      jtl: Alcohol & Alcoholism
      issn: 07350414
      maglogo: N
    pubinfo:
      dt: Jan2020
      vid: 55
      iid: 1
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        141628102
        141628102
        141628102
        10.1093/alcalc/agz089
        141628102
      ppf: 28
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Associations of Liver Disease with Alcohol Use among People Living with HIV and the Role of Hepatitis C: The New Orleans Alcohol Use in HIV Study.
      aug:
        au:
          Ferguson, Tekeda F
          Rosen, Erika
          Carr, Rotonya
          Brashear, Meghan
          Simon, Liz
          Theall, Katherine P
          Ronis, Martin J
          Welsh, David A
          Molina, Patricia E
        affil: Louisiana State University Health Sciences Center, Comprehensive Alcohol Research Center, 1901 Perdido Street, New Orleans, Louisiana 70112, LA, USA
      sug:
        subj:
          HIV-Positive Persons
          Liver Diseases
          Alcohol Drinking
          Hepatitis C
          Coinfection
          Human
          Cross Sectional Studies
          Comorbidity
          Questionnaires
          Clinical Assessment Tools
          Substance Use Disorders Diagnosis
          Phospholipids Blood
          Aminotransferases Blood
          Blood Platelets
          Fibrosis
          Nonalcoholic Fatty Liver Disease
          Multiple Logistic Regression
          Male
          Female
          Adult
          Middle Age
          Descriptive Statistics
          Binge Drinking
          Liver Cirrhosis
          Biological Markers Blood
          Sex Factors
          Odds Ratio
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Male
          Female
      ab: Aim This cross-sectional analysis of the New Orleans Alcohol Use in HIV (NOAH) study assesses whether current and lifetime alcohol use in people living with HIV (PLWH) are associated with greater liver disease and how hepatitis C-viral (HCV) co-infection (HIV/HCV+) modifies the association. Methods Alcohol use was measured by Lifetime Drinking History (LDH), a 30-day Timeline Followback calendar, the Alcohol Use Disorder Identification Test, and phosphatidylethanol. Liver disease was estimated by alanine aminotransferase (ALT), aspartate aminotransferase (AST), AST platelet ratio-index (APRI), fibrosis-4 index (FIB-4) and nonalcoholic fatty liver disease-fibrosis score. Associations between alcohol consumption and liver disease were estimated with multivariable logistic regression. Models were adjusted for age, sex, body-mass index, hepatitis B and HIV viral load. Results Participants (N  = 353) were majority male (69%) and black (84%) with a mean age of 48.3 ± 10 years. LDH was significantly associated with advanced liver fibrosis (FIB-4 aOR = 22.22 [1.22–403.72]) only among HIV/HCV+ participants with an LDH of 100–600 kg. HIV/HCV+ participants had a higher prevalence of intermediate and advanced liver disease markers than HIV/HCV− (P  < 0.0001). Advanced markers of liver disease were most strongly associated with hazardous drinking (≥40(women)/60(men) grams/day) (APRI aOR = 15.87 (3.22–78.12); FIB-4 aOR = 6.76 (1.81–7.16)) and PEth ≥400 ng/ml (APRI aOR = 17.52 (2.55–120.54); FIB-4 aOR = 17.75 (3.30–95.630). Conclusion Results indicate a greater association of current alcohol use with liver disease than lifetime alcohol use, which varied by HCV status. These findings stress the importance of reducing alcohol use in PLWH to decrease risk of liver disease and fibrosis.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N